Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era?-Reference-Cited by-同舟云学术

Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era?

Published:2018-12 Issue:4 Volume:31 Page:357-360
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Litzow Mark R.

Funder

Amgen

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference23 articles.

1. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance;Secker-Walker;Leukemia,1991

2. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial;Dombret;Blood,2002

3. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

4. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia;Forman;Blood,1987

5. Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia;Chao;Blood,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission;American Journal of Hematology;2024-02-05

2. Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia;International Journal of Hematology;2023-02-20

3. Management of Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia;Pathogenesis and Treatment of Leukemia;2023

4. Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Clinical Management of Acute Lymphoblastic Leukemia;2022

5. Comparison of allogeneic hematopoietic stem cell transplantation and TKI combined with chemotherapy for adult philadelphia chromosome positive acute lymphoblastic leukemia: a systematic review and meta‐analysis;Cancer Medicine;2021-11-11